高甘油三酯血症是心肌梗塞病人最常见的脂蛋白异常。研究高甘油三酯血症与缺血性心脏病(1HD)之关系的结果颇不一致。特别是安妥明(Clofibrate)治疗,虽能降低非致命性的IHD(non-fatal IHD)发生率,但总死亡率增高,从而使人们对高甘油三酯血症是否应当治疗这个问题感到怀疑。另一方面,有些研究提示,在高甘油三酯 Hypertriglyceridemia is the most common lipoprotein abnormality in patients with myocardial infarction. The results of the study on the relationship between hypertriglyceridemia and ischemic heart disease (1HD) are quite different. Clofibrate in particular, while reducing the incidence of non-fatal IHD but increasing overall mortality, cast doubts as to whether hypertriglyceridemia should be treated. On the other hand, some studies suggest that in high triglycerides